ERNA Stock Analysis: Buy, Sell, or Hold?
ERNA - Ernexa Therapeutics Inc. Common Stock
$7.53
-0.29 (-3.71%)
▼
5d:
+4837.7%
30d:
+3553.57%
90d:
+1901.06%
SELL
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When ERNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
6 traders called ERNA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⚠️ CAUTION: ERNA is extended with warning signals. Consider taking profits or waiting for better entry.
⚠️ CAUTION: ERNA is extended with warning signals. Consider taking profits or waiting for better entry.
In-depth Analysis How we analyze
Valuation Analysis: ERNA is currently trading at $7.53, which is considered extended relative to its 30-day fair value range of $-1.08 to $3.41.
Technical Outlook: Technically, ERNA is showing sideways momentum. Immediate support is located at $0.13, while resistance sits at $8.49. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $3.00. Given the valuation headwinds and technical position, caution is warranted at these levels.
Technical Outlook: Technically, ERNA is showing sideways momentum. Immediate support is located at $0.13, while resistance sits at $8.49. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: ERNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $3.00. Given the valuation headwinds and technical position, caution is warranted at these levels.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-1.08 -
$3.41
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
31.6%
All Signals
- BEARISH: Price significantly overextended (+120.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-3.7%)
- BEARISH: Trading 60.2% above Wall St target ($3.00)
Trading Range Analysis
30-Day Trading Range
$-1.08 -
$3.41
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$8.49
Current Trend
Sideways
Technical data as of
May 8, 2026
Fundamental Context
Wall Street Target
$3.00
(-60.2%)
Revenue Growth (YoY)
-94.1%
Share & Embed Analysis
Last updated: May 10, 2026 3:20 PM ET
Data refreshes hourly during market hours. Next update: 4:20 PM
Data refreshes hourly during market hours. Next update: 4:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 46 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
